Market Research Reports and Industry Reports

BioElectron Technology Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

BioElectron Technology Corp(BioElectron) formerly known as Edison Pharmaceuticals Inc, discovers and develops shared (redox) disease drugs. The companys pipeline products comprise EPI-743, a drug candidate for inherited mitochondrial diseases and EPI-589 drug candidate entering phase 1 clinical trials. It conducts multiple phase 2 clinical trials in diseases where mitochondrial dysfunction is involved. Edison Pharmaceuticals also develops treatments for other neurological diseases with shared disease mechanisms. The company develops drugs for treatment of rare mitochondrial diseases for children. It operates in the US and the Netherlands. BioElectron is headquartered in Mountain View, California, the US.

BioElectron Technology Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioElectron Technology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioElectron Technology Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioElectron Technology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioElectron Technology Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
BioElectron Technology Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
BioElectron Technology Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Edison Pharma Raises US$20 Million In Series F Financing 10
Edison Pharma Secured US$4.1 Million In Series E Financing 11
Licensing Agreements 12
Edison Pharma Expands Licensing Agreement With Dainippon Sumitomo Pharma 12
Edison Pharma Enters Into Licensing Agreement With Dainippon Sumitomo Pharma For EPI-743 And EPI-589 14
BioElectron Technology Corp - Key Competitors 16
BioElectron Technology Corp - Key Employees 17
BioElectron Technology Corp - Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Clinical Trials 19
Jun 23, 2016: Edison Pharmaceuticals Announces Positive Results from Phase 2 Placebo - Controlled EPI - 743 Leigh Syndrome Trial 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List Of Tables

List of Tables
BioElectron Technology Corp, Pharmaceuticals & Healthcare, Key Facts 2
BioElectron Technology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioElectron Technology Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioElectron Technology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioElectron Technology Corp, Deals By Therapy Area, 2011 to YTD 2017 8
BioElectron Technology Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Edison Pharma Raises US$20 Million In Series F Financing 10
Edison Pharma Secured US$4.1 Million In Series E Financing 11
Edison Pharma Expands Licensing Agreement With Dainippon Sumitomo Pharma 12
Edison Pharma Enters Into Licensing Agreement With Dainippon Sumitomo Pharma For EPI-743 And EPI-589 14
BioElectron Technology Corp, Key Competitors 16
BioElectron Technology Corp, Key Employees 17
BioElectron Technology Corp, Other Locations 18

BioElectron Technology Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

BioElectron Technology Corp(BioElectron) formerly known as Edison Pharmaceuticals Inc, discovers and develops shared (redox) disease drugs. The companys pipeline products comprise EPI-743, a drug candidate for inherited mitochondrial diseases and

USD 250View Report

BioElectronics Corporation Strategic Analysis Review- BioElectronics Corporation SWOT, Outlook, Operations and Financial Profile

BioElectronics Corporation Company Profile provides strategic analysis of BioElectronics Corporation Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth opportunities available

USD 200View Report

TaiDoc Technology Corporation (4736) - Financial and Strategic SWOT Analysis Review

TaiDoc Technology Corporation (4736) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125View Report

Solar Applied Materials Technology Corp (1785) - Financial and Strategic SWOT Analysis Review

Solar Applied Materials Technology Corp (Solar) is a manufacturer of optical data storage thin film. The company provides key materials and integrated service model for application optoelectronics, petrochemicals and consumer

USD 300View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)


+91 9987 2952 42

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Dec 2017
No. of Pages :20
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube